{
    "organizations": [],
    "uuid": "03b79d7d91a246a7dce10732a200c0a90c4257f6",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-glenmark-pharmaceuticals-submitts/brief-glenmark-pharmaceuticals-submitts-nda-to-u-s-fda-for-ryaltris-idUSFWN1SS0OY",
    "ord_in_thread": 0,
    "title": "BRIEF-Glenmark Pharmaceuticals Submitts NDA To U.S. FDA For Ryaltris",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "May 21 (Reuters) - Glenmark Pharmaceuticals Ltd:\n* GLENMARK PHARMACEUTICALS - SUBMITTED NDA TO U.S. FDA FOR LEADING RESPIRATORY PIPELINE CANDIDATE RYALTRIS Source text for Eikon: Further company coverage:\n ",
    "published": "2018-05-22T03:33:00.000+03:00",
    "crawled": "2018-05-22T19:36:28.012+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "may",
        "reuters",
        "glenmark",
        "pharmaceutical",
        "ltd",
        "glenmark",
        "pharmaceutical",
        "submitted",
        "nda",
        "fda",
        "leading",
        "respiratory",
        "pipeline",
        "candidate",
        "ryaltris",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}